Knight Therapeutics Inc.

News & Events

Press Releases

In The Media

1. Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City

   GlobeNewswire MAY 13, 2025 7:30 AM EDT
   MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:  GUD) ("Knight"), ...
   READ ARTICLE

2. Knight Therapeutics Reports First Quarter 2025 Results

   GlobeNewswire MAY 8, 2025 7:30 AM EDT
   MONTREAL, May 08, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or ...
   READ ARTICLE

3. Knight Therapeutics Inc. announces voting results from the Annual General Meeting

   GlobeNewswire MAY 7, 2025 5:10 PM EDT
   MONTREAL, May 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "C...
   READ ARTICLE

4. Knight Therapeutics Announces Relaunch of ONICIT® in Brazil and Mexico

   GlobeNewswire MAY 7, 2025 7:30 AM EDT
   MONTREAL, May 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-...
   READ ARTICLE

5. Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call

   GlobeNewswire MAY 1, 2025 7:30 AM EDT
   MONTREAL, May 01, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight&#x...
   READ ARTICLE

6. Knight to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

   GlobeNewswire APR 29, 2025 4:30 PM EDT
   MONTREAL, April 29, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight&...
   READ ARTICLE

7. Knight Therapeutics Inc. ranks on The Globe and Mail's sixth-annual Women Lead Here benchmark of executive gender diversity

   GlobeNewswire MAR 28, 2025 6:06 PM EDT
   MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight&...
   READ ARTICLE

8. Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico

   GlobeNewswire MAR 26, 2025 7:30 AM EDT
   MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a p...
   READ ARTICLE

9. Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results

   GlobeNewswire MAR 20, 2025 7:30 AM EDT
   MONTREAL, March 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or &#x...
   READ ARTICLE

10. Notice of Knight Therapeutics' Fourth Quarter and Year End 2024 Results Conference Call

    GlobeNewswire MAR 13, 2025 7:30 AM EDT
    MONTREAL, March 13, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight&...
    READ ARTICLE